Melanie Wannick


Research Center Borstel
Parkallee 1-40
23845 Borstel

Email:
Phone:
+49 451 500 50893
Fax:
+49 451 500 5088

Publications

2019

  • Thieme, M., Bieber, K., Sezin, T., Wannick, M., Gupta, Y., Kalies, K., Ludwig, R. J., Mousavi, S., Zillikens, D. and Sadik, C. D.: The Sphingosine-1-Phosphate Receptor Modulator Fingolimod Aggravates Murine Epidermolysis Bullosa Acquisita J. Invest. Dermatol., n, 2019
    BibTeX Pubmed Auszeichnung
    % 31176709 
    @Article{pmid31176709,
       Author="Thieme, M.  and Bieber, K.  and Sezin, T.  and Wannick, M.  and Gupta, Y.  and Kalies, K.  and Ludwig, R. J.  and Mousavi, S.  and Zillikens, D.  and Sadik, C. D. ",
       Title="{{T}he {S}phingosine-1-{P}hosphate {R}eceptor {M}odulator {F}ingolimod {A}ggravates {M}urine {E}pidermolysis {B}ullosa {A}cquisita}",
       Journal="J. Invest. Dermatol.",
       Year="2019",
       Month="Jun"
    }

2018

  • Wannick, M., Bezdek, S., Guillen, N., Thieme, M., Meshrkey, F., Mousavi, S., Seeling, M., Nimmerjahn, F., Mocsai, A., Zillikens, D., Sezin, T. and Sadik, C. D.: Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases Pharmacol Res Perspect, vol. 6, no. 6, pp. e00438, 2018
    BibTeX Pubmed Auszeichnung
    % 30455959 
    @Article{pmid30455959,
       Author="Wannick, M.  and Bezdek, S.  and Guillen, N.  and Thieme, M.  and Meshrkey, F.  and Mousavi, S.  and Seeling, M.  and Nimmerjahn, F.  and Mocsai, A.  and Zillikens, D.  and Sezin, T.  and Sadik, C. D. ",
       Title="{{O}ral administration of the selective {G}{P}{R}120/{F}{F}{A}4 agonist compound {A} is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases}",
       Journal="Pharmacol Res Perspect",
       Year="2018",
       Volume="6",
       Number="6",
       Pages="e00438",
       Month="12"
    }